The Journal of Pediatrics
Volume 150, Issue 5 , Pages 479-484 , May 2007

Effect of Fish Oil Supplementation on Fatty Acid Status, Coordination, and Fine Motor Skills in Children with Phenylketonuria

  • Skadi Beblo, MD

      Affiliations

    • Current address for S.B.: Dept. of Pediatrics, Univ. of Leipzig, Oststr 21-25, 04317 Leipzig, Germany.
    • S.B. received a scholarship from the University of Munich (3. Hochschulsonderprogramm, Ludwig-Maximilians-Universität München, Germany).
    • ,
  • Hannes Reinhardt, BSc
    • ,
  • Hans Demmelmair, PhD
    • ,
  • Ania C. Muntau, MD
    • ,
  • Berthold Koletzko, MD

      Affiliations

    • B.K. is the recipient of a Freedom to Discover Grant of the Bristol Myers Squibb Foundation, New York, New York.
    • Corresponding Author InformationReprint requests: Dr Berthold Koletzko, Professor of Paediatrics, Div. Metabolic Diseases and Nutritional Medicine, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-University of Munich, Lindwurmstr. 4, D-80337 Muenchen, Germany.

Received 19 April 2006 ,Revised 16 September 2006 ,Accepted 1 December 2006.

References 

  1. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In:  Scriver RC,  Beaudet AL,  Sly WS,  Valle D editor. The Metabolic and Molecular Basis of Inherited Disease. 7th ed.. New York: McGraw-Hill; 1998;p. 1015–1075
  2. Koch R, Azen C, Friedman EG, Williamson ML. Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age. J Inher Metab Dis. 1984;7:86–90
  3. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr. 1996;155(suppl 1):S33–S38
  4. Stemerdink BA, Kalverboer AF, van der Meere JJ, van der Molen MW, Huisman J, de Jong LWA, et al. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inher Metab Dis. 2000;23:548–562
  5. Schmidt E, Burgard P, Rupp A. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr. 1996;155(suppl 1):S82–S86
  6. Burgard P, Rey F, Rupp A, Abadie V, Rey J. Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res. 1997;41:368–374
  7. Pietz J, Benninger C, Schmidt H, Scheffner D, Bickel H. Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr. 1988;147:361–367
  8. Pietz J, Dunckelmann R, Rupp A, Rating D, Meinck HM, Schmidt H, et al. Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr. 1998;157:824–830
  9. Arnold GL, Kramer BM, Kirby RS, Plumeau PB, Blakely EM, Sanger Cregan LS, et al. Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria. Acta Paediatrica. 1998;87:565–570
  10. Acosta PB, Fernhoff PM, Warshaw HS, Elsas LJ, Hambidge KM, Ernest A, et al. Zinc status and growth of children undergoing treatment for phenylketonuria. J Inher Metab Dis. 1982;5:107–110
  11. Gropper SS, Acosta PB, Clarke-Sheehan N, Wenz E, Cheng M, Koch R. Trace element status of children with PKU and normal children. J Am Dietetic Association. 1988;88:459–465
  12. Bodley JL, Austin VJ, Hanley WB, Clarke JT, Zlotkin S. Low iron stores in infants and children with treated phenylketonuria: a population at risk for iron-deficiency, anemia and associated cognitive deficits. Eur J Pediatr. 1993;152:140–143
  13. Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J. Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutrition. 1999;70:892–895
  14. Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr. 1991;119:562–567
  15. Poge AP, Baumann K, Muller E, Leichsenring M, Schmidt H, Bremer HJ. Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inher Metab Dis. 1998;21:373–381
  16. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA. 1986;83:4021–4025
  17. Reisbick S, Neuringer M, Hasnain R, Connor WE. Home cage behavior of rhesus monkeys with long-term deficiency of omega-3 fatty acids. Physiol Behav. 1994;55:231–239
  18. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201–209
  19. Decsi T, Koletzko B. Role of long-chain polyunsaturated in early human neurodevelopment. Nutrition Neurosci. 2000;3:293–306
  20. Neuringer M. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications. Am J Clin Nutrition. 2000;71:256S–267S
  21. Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology. 2001;57:1488–1491
  22. Deutsche Gesellschaft für Ernährung. Ernährungsbericht 1996. Franfurt/Main: Umschau Baus; 1996;
  23. Kurth E. Motometrische Rostock-Oseretzky-Skala. Psychodiagnostisches Zentrum Berlin: Sektion Psychologie der Humboldt-Universität; 1985;
  24. Decsi T, Koletzko B. Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood. Eur J Pediatr. 1994;153:520–525
  25. Lawrence DG, Hopkins DA. The development of motor control in the rhesus monkey: evidence concerning the role of corticomotoneuronal connections. Brain. 1976;99:235–254
  26. Forssberg H, Eliasson AC, Kinoshita H, Johansson RS, Westling G. Development of human precision grip (I: basic coordination of force). Exp Brain Res. 1991;85:451–457
  27. Kuhtz-Buschbeck JP, Stolze H, Johnk K, Boczek-Funcke A, Illert M. Development of prehension movements in children: a kinematic study. Exp Brain Res. 1998;122:424–432
  28. Brumm VL, Azen C, Moats RA, Stern AM, Broomand C, Nelson MD, et al. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J Inherit Metab Dis. 2004;27:549–566
  29. Koletzko B, Aggett PJ, Bindels JG, Bung P, Ferre P, Gil A, et al. Growth, development and differentiation: a functional food science approach. Brit J Nutrition. 1998;80(suppl 1):S5–S45
  30. Martinez M, Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem. 1998;71:2528–2533
  31. Koletzko B, Demmelmair H, Hartl W, Kindermann A, Koletzko S, Sauerwald T, et al. The use of stable isotope techniques for nutritional and metabolic research in paediatrics. Early Hum Dev. 1998;53(suppl):S77–S97
  32. Heird WC, Prager TC, Anderson RE. Docosahexaenoic acid and the development and function of the infant retina. Curr Opin Lipidol. 1997;8:12–16
  33. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids. 1992;27:901–907
  34. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Deve Med Child Neurol. 2000;42:174–181
  35. Bick U, Fahrendorf G, Ludolph AC, Vassallo P, Weglage J, Ullrich K. Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr. 1991;150:185–189
  36. Bick U, Ullrich K, Stober U, Moller H, Schuierer G, Ludolph AC, et al. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr. 1993;152:1012–1020
  37. Weglage J, Schuierer G, Kurlemann G, Bick R, Ullrich K. Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging. J Inher Metab Dis. 1993;16:1047–1048
  38. Weglage J, Bick U, Schuierer G, Pietsch M, Sprinz A, Zass R, et al. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence. Neuropediatrics. 1997;28:239–240
  39. Ludolph AC, Vetter U, Ullrich K. Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability. Eur J Pediatr. 1996;155(suppl 1):S64–S68
  40. Ullrich K, Weglage J, Oberwittler C, Pietsch M, Funders B, von Eckardstein H, et al. Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. Eur J Pediatr. 1996;155(suppl 1):S74–S77
  41. Agostoni C, Massetto N, Biasucci G, Rottoli A, Bonvissuto M, Bruzzese MG, et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr. 2000;137:504–509
  42. Martinez M, Vazquez E. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology. 1998;51:26–32

 Supported in part by Scientific Hospital Supplies, Heilbronn, Germany, and the Child Health Foundation, Munich, Germany. Fish oil capsules were provided by Omega-Pharma, Berlin, Germany.

PII: S0022-3476(06)01174-7

doi: 10.1016/j.jpeds.2006.12.011

The Journal of Pediatrics
Volume 150, Issue 5 , Pages 479-484 , May 2007

Article Tools